
What We're Reading: Anthem, Aetna Merger Lawsuits Unlikely to Be Decided by End of 2016
What we're reading, August 5, 2016: judge assigned to Anthem-Cigna and Aetna-Humana cases said he would likely only rule on one by the end of 2016; aversion to late-term abortion plummets when Zika infection is a factor; and the National Institutes of Health proposes lifting ban on research funds for human-animal stem cell research.
A judge responsible for deciding if the government can block the proposed mergers of Aetna-Humana and Anthem-Cigna has indicated both cases are unlikely to be decided by the end of the year.
Americans’ aversion to late-term abortion plummets in the case pregnant women infected with the Zika virus,
The National Institutes of Health (NIH) is proposing to lift the ban on research funds for human-animal stem cell research. NIH had imposed a ban because these experiments could raise ethical concerns, but a new policy would let scientists receive federal money to make animal embryos that are partly human under carefully monitored conditions,
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.